ELISA detection of SARS-CoV-2 antibodies in saliva
Abstract
To facilitate containment of the COVID-19 pandemic currently active in the United States and across the world, options for easy, non-invasive antibody testing are required. Here we have adapted a commercially available, serum-based ELISA for use with saliva samples, which will enable widespread, affordable testing for patients who experienced this disease.
Related articles
Related articles are currently not available for this article.